| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1378954 | Bioorganic & Medicinal Chemistry Letters | 2005 | 4 Pages |
Abstract
The development of a novel series of 4-aryl, 4-phenylsulfonyl cyclohexananone-derived γ-secretase inhibitors for the potential treatment of Alzheimer’s disease is described.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Martin Teall, Paul Oakley, Timothy Harrison, Duncan Shaw, Euan Kay, Jason Elliott, Ute Gerhard, José L. Castro, Mark Shearman, Richard G. Ball, Nancy N. Tsou,